<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="11991" OLDID="219" TOPICS="YES">
<DATE> 1-APR-1987 10:54:12.09</DATE>
<TOPICS/>
<PLACES><D>usa</D><D>uk</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 

   F
   f1236 reute
r f BC-GENETICS-&lt;GENI&gt;,-WELL   04-01 0086</UNKNOWN>
<TEXT> 
<TITLE>GENETICS &lt;GENI&gt;, WELLCOME NAME SITE FOR VENTURE</TITLE>
<DATELINE>    CAMBRIDGE, Mass., April 1 - </DATELINE><BODY>Genetics Institute Inc and
Wellcome PLC, a British-based pharmaceutical company, jointly
announced the selection of a site for their joint venture,
WelGen Manufacturing Inc, formed last September.
    The companies said they choose a 77-acre site in West
Greenwich R.I. for the venture's manufacturing facility, which
will make biotechnology-based pharmaceuticals. The plant should
be completed in 1989, and will employ about 200 people.
 Reuter
 </BODY></TEXT>
</REUTERS>